Hypertrophic cardiomyopathy (HCM), which was first described in 1958, occurs in approximately one in 500 people. Patients with HCM are at an increased risk of atrial fibrillation, which is not ...
Vitamin K antagonists, such as warfarin, have an unpredictable pharmacokinetic profile and numerous food and drug interactions, which need frequent monitoring, creating a burden for patients and ...
Context: On the basis of theoretical rationale, heparoids and vitamin K antagonists are prescribed ... molecular-weight heparins or thrombolytic drugs have been done; therefore, their efficacy ...